2022
DOI: 10.3389/fnmol.2022.888716
|View full text |Cite
|
Sign up to set email alerts
|

Non-invasive Brain Stimulation for Chronic Pain: State of the Art and Future Directions

Abstract: As a technique that can guide brain plasticity, non-invasive brain stimulation (NIBS) has the potential to improve the treatment of chronic pain (CP) because it can interfere with ongoing brain neural activity to regulate specific neural networks related to pain management. Treatments of CP with various forms of NIBS, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), using new parameters of stimulation have achieved encouraging results. Evidence of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 103 publications
(125 reference statements)
0
17
0
Order By: Relevance
“…Nociceptive stimulation activates glutamate NMDA receptors, leading to calcium infux, and triggering the calcium-dependent intracellular pathway to induce LTP, notably the calcium/calmodulin-dependent protein kinase II (CaMKII) pathway [9,39]. LTP was shown to be associated with the analgesic mechanisms in NIBS [40]. It has been reported that rTMS reduces central sensitization by 70% according to the central sensitization inventory score [41].…”
Section: Discussionmentioning
confidence: 99%
“…Nociceptive stimulation activates glutamate NMDA receptors, leading to calcium infux, and triggering the calcium-dependent intracellular pathway to induce LTP, notably the calcium/calmodulin-dependent protein kinase II (CaMKII) pathway [9,39]. LTP was shown to be associated with the analgesic mechanisms in NIBS [40]. It has been reported that rTMS reduces central sensitization by 70% according to the central sensitization inventory score [41].…”
Section: Discussionmentioning
confidence: 99%
“…Non-invasive brain stimulation (NiBS) technology has been regarded as an important innovation in neuropsychiatric diseases and chronic pain (including migraine) in recent years and widely used in clinical settings (10)(11)(12)(13). Transcranial magnetic stimulation (TMS), which applied a magnetic field to the surface of the scalp and induces current in the subjacent cortex (14), is an effective and safe approach that has been approved by the FDA for migraine treatment (15, 16).…”
Section: Introductionmentioning
confidence: 99%
“…Bioelectronic medicine uses the body’s electrical signals to improve the diagnosis and treatment of disease. As an emerging bioelectronic medical technology, Non-invasive brain stimulation (NIBS) has been widely used in clinical treatment, particularly for pain ( Xiong et al, 2022 ), neuronal function regulation, brain function cognition, behavior, and other aspects of the evident treatment effect ( Miniussi and Ruzzoli, 2013 ). NIBS not only brings hope for treating diseases that cannot be solved by common drugs and medical means, but also provides drug alternatives with rapid and precise targeting.…”
Section: Introductionmentioning
confidence: 99%